These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 1573269)
1. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4. Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269 [TBL] [Abstract][Full Text] [Related]
2. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase. Ebanks RO; Isenman DE J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551 [TBL] [Abstract][Full Text] [Related]
3. The coding sequence of the hemolytically inactive C4A6 allotype of human complement component C4 reveals that a single arginine to tryptophan substitution at beta-chain residue 458 is the likely cause of the defect. Anderson MJ; Milner CM; Cotton RG; Campbell RD J Immunol; 1992 May; 148(9):2795-802. PubMed ID: 1573268 [TBL] [Abstract][Full Text] [Related]
4. The low C5 convertase activity of the C4A6 allotype of human complement component C4. Kinoshita T; Dodds AW; Law SK; Inoue K Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239 [TBL] [Abstract][Full Text] [Related]
5. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. Brown EJ; Ramsey J; Hammer CH; Frank MM J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833 [TBL] [Abstract][Full Text] [Related]
6. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity. Ebanks RO; Isenman DE Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451 [TBL] [Abstract][Full Text] [Related]
7. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor. Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408 [TBL] [Abstract][Full Text] [Related]
8. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. Isenman DE; Young JR J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966 [TBL] [Abstract][Full Text] [Related]
9. Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4. Reilly BD; Levine RP; Skanes VM J Immunol; 1991 Nov; 147(9):3018-23. PubMed ID: 1919003 [TBL] [Abstract][Full Text] [Related]
10. A covalent dimer of complement C4b serves as a subunit of a novel C5 convertase that involves no C3 derivatives. Masaki T; Matsumoto M; Yasuda R; Levine RP; Kitamura H; Seya T J Immunol; 1991 Aug; 147(3):927-32. PubMed ID: 1861081 [TBL] [Abstract][Full Text] [Related]
11. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway. Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629 [TBL] [Abstract][Full Text] [Related]
12. Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway. Masaki T; Matsumoto M; Hara T; Nakanishi I; Kitamura H; Seya T Mol Immunol; 1995 Jan; 32(1):21-6. PubMed ID: 7870055 [TBL] [Abstract][Full Text] [Related]
13. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation. Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65. Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193 [TBL] [Abstract][Full Text] [Related]
15. Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces. Isenman DE; Young JR J Immunol; 1986 Apr; 136(7):2542-50. PubMed ID: 3512717 [TBL] [Abstract][Full Text] [Related]
16. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Blanchong CA; Chung EK; Rupert KL; Yang Y; Yang Z; Zhou B; Moulds JM; Yu CY Int Immunopharmacol; 2001 Mar; 1(3):365-92. PubMed ID: 11367523 [TBL] [Abstract][Full Text] [Related]
17. Regulation and deregulation of the fluid-phase classical pathway C3 convertase. Gigli I; Sorvillo J; Halbwachs-Mecarelli L J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705 [TBL] [Abstract][Full Text] [Related]
18. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b. Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein. Saint-Remy JM Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450 [TBL] [Abstract][Full Text] [Related]
20. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase. Rawal N; Pangburn MK Mol Immunol; 2007 Feb; 44(6):1105-14. PubMed ID: 16979240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]